Absonutrix
Comprehensive Brand Analysis
Fast Facts
Company History & Milestones
• 2017 — Received an FDA Warning Letter (July 25, 2017) for misbranding and promoting products with drug claims. ([U.S. Food and Drug Administration][4])
• 2019 — Received an FDA Warning Letter (August 26, 2019) for CGMP violations in manufacturing of dietary supplements. ([U.S. Food and Drug Administration][3])
• 2025 — Brand website claims “10+ years of expertise” and “100+ countries covered,” indicating international distribution. ([absonutrix.com][1])
Product & Manufacturing Profile
Core Products
N/A
Manufacturing Model
The company indicates U.S. manufacturing (“Made in USA”), “GMP Standard” production, and capability for private label/contract manufacturing. ([absonutrix.com][1])
Quality Certifications
The website claims “GMP Standard” but does not clearly list third-party certifications (e.g., NSF or USP) with certificate numbers. ([absonutrix.com][1])
Third-Party Testing
No publicly accessible full batch Certificates of Analysis (COAs) found; FDA inspection history shows compliance issues which suggest deficiencies in quality controls. ([U.S. Food and Drug Administration][3])
Transparency
Ingredient Sourcing
Their website highlights “high quality organic and 100% natural botanicals” and claims “Made in USA” with domestic manufacturing. ([absonutrix.com][1]) However, detailed raw-material origin or supplier traceability is not broadly published.
Published Testing
While the brand asserts GMP and manufacturing standards, no clear public portal for lot-specific COAs or independent testing reports was located. The FDA warning in 2019 cited failure to verify identity of incoming ingredients. ([U.S. Food and Drug Administration][3])
Sustainability
No substantial public disclosure of sustainability initiatives (e.g., packaging, sourcing impact, environmental footprint) was found in the reviewed materials.
Trust Score
Sources
- Absonutrix Official Website – [https://www.absonutrix.com/](https://www.absonutrix.com/) – Brand claims and manufacturing statements.
- FDA Warning Letter – Absonutrix, LLC (Case 583992) August 26, 2019 – [https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/absonutrix-llc-583992-08262019/](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/absonutrix-llc-583992-08262019/) – CGMP violations.
- FDA Warning Letter – Absonutrix (Case 508557) July 25, 2017 – [https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/absonutrix-508557-07252017/](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/absonutrix-508557-07252017/) – Misbranding.
Featured Ingredients
Where to Buy This Supplement
Affiliate Disclosure: We earn a commission if you purchase through these links at no additional cost to you. This helps us maintain our research and provides you with the best supplement information.